Next 10 |
2024-04-27 15:39:17 ET More on Amgen, Cullinan Oncology, etc. Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock Cullinan Therapeutics expands into autoim...
2024-04-27 10:27:00 ET Summary NKTX is now down over 50% from its March 2024 highs. The company's pipeline includes NKX019, a CAR-NK cell therapy with potential in cancer and autoimmune disease. NKTX has already produced some data with NKX019 in oncology with more data coming ...
2024-04-06 21:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-25 16:03:27 ET Summary Release of results from the phase 1 study, using NKX019 for the treatment of patients with relapsed/refractory NHL, expected mid-2024; this is using a compressed dosing schedule. The global non-Hodgkin's Lymphoma market is expected to reach $20 billi...
2024-03-25 10:00:59 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&...
2024-03-25 07:27:03 ET DENVER, Colo., Mar 25, 2024 ( 247marketnews.com )- Nkarta, Inc. (NASDAQ: NKTX ) stated, this morning, that it priced an underwritten offering of 21,010,000 shares of its common stock at a price of $10.00 per share and pre-funded warrants to purchase 3,000,031 ...
2024-03-25 07:26:02 ET More on Nkarta Nkarta's Strategic Advances In Cell Therapy For Autoimmune Disorders Nkarta: Possible Upside From H1 Update, If Positive Seeking Alpha’s Quant Rating on Nkarta Read the full article on Seeking Alpha For fur...
SOUTH SAN FRANCISCO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced the pricing of an underwritten offering of 21,010,000 shares of its common stock at a price of $10.00 ...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 4.2% to $0.1248 on volume of 179,379,334 shares Biolase Inc. (BIOL) rose 19.5% to $0.1793 on volume of 129,349,610 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 0.6% to $3.22 on volume o...
2024-03-22 13:02:29 ET More on Mid-day movers & stocks. Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Aemetis, Inc. (AMTX) Q4 2023 Earnings Call Transcript Aemetis, Inc. 2023 Q4 - Results - Earnings Call Presentation Aemetis surges after USCIS ap...
News, Short Squeeze, Breakout and More Instantly...
Nkarta Inc. Company Name:
NKTX Stock Symbol:
NASDAQ Market:
Thursday, Century Therapeutics (NASDAQ:IPSC) unveiled plans to expand clinical development for its lead program, CNTY-101, a CD19-targeti...
2024-04-06 21:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 whil...